# EDGAR Filing Document

**Accession Number:** 0002081456
**File Stem:** 0002081456-26-000002
**Filing Date:** 2026-2
**Character Count:** 7555
**Document Hash:** 256e00675a45ef9f44427e048df16265
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002081456-26-000002.hdr.sgml**: 20260223

**ACCESSION NUMBER**: 0002081456-26-000002

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260223

**DATE AS OF CHANGE**: 20260223

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Processa Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001533743
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 451539785
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90420
- **FILM NUMBER:** 26662722

**BUSINESS ADDRESS:**
- **STREET 1:** 601 21ST STREET, SUITE 300
- **CITY:** VERO BEACH
- **STATE:** FL
- **ZIP:** 32960
- **BUSINESS PHONE:** 443-776-3133

**MAIL ADDRESS:**
- **STREET 1:** 601 21ST STREET, SUITE 300
- **CITY:** VERO BEACH
- **STATE:** FL
- **ZIP:** 32960

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Heatwurx, Inc.
- **DATE OF NAME CHANGE:** 20111028
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Chiliz Group Ltd.
- **CENTRAL INDEX KEY:** 0002081456

**ORGANIZATION NAME:**
- **EIN:** 998164932
- **STATE OF INCORPORATION:** O1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 6, WEMBLEY BUSINESS CENTRE
- **STREET 2:** 179, RUE D'ARGENS
- **CITY:** MSIDA
- **NON US STATE TERRITORY:** MSD
- **PROVINCE COUNTRY:** O1
- **ZIP:** 1360
- **BUSINESS PHONE:** 35699997878

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 6, WEMBLEY BUSINESS CENTRE
- **STREET 2:** 179, RUE D'ARGENS
- **CITY:** MSIDA
- **NON US STATE TERRITORY:** MSD
- **PROVINCE COUNTRY:** O1
- **ZIP:** 1360

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HX Entertainment Ltd
- **DATE OF NAME CHANGE:** 20250813

### Attached PDF Documents

**Attachment 1:** `Exhibit1PCSASPAPIPE.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**Processa Pharmaceuticals, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**74275C403**

*(CUSIP Number)*

**Michelle Reihel**<br>2029 Century Park East<br>Suite 400<br>Los Angeles CA 90067<br>(213) 596-5620

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**02/13/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **74275C403** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**HX Entertainment Ltd** | Name of reporting person<br>**HX Entertainment Ltd** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**O1** | Citizenship or place of organization<br>**O1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**305644.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**305644.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**305644.00** | Aggregate amount beneficially owned by each reporting person<br>**305644.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**13.0%** | Percent of class represented by amount in Row (11)<br>**13.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Processa Pharmaceuticals, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
601 21ST STREET, SUITE 300, 601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960

**Item 4. Purpose of Transaction**

No material change from Amendment number one.  The additional investment is consistent with The Chiliz Group's previously disclosed investment purpose and strategic interest in the Issuer.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Chiliz Group (formally, HX Entertainment) beneficially owns 305,644 shares of Common Stock, representing approximately 13.0% of the outstanding Common Stock of the Issuer.  The percentage of class beneficially owned was calculated based on 56,644,223 share of Common Stock outstanding as of November 3, 2025, as reported by the Issuer on the cover page of its Quarterly Report on Form 10-Q for the quarter of September 30, 2025, which amount has been adjusted to reflect the Issuer's 1-for-25 reverse stock split effective December 16, 2025 (resulting in approximately 2,265, 769 shares outstanding on a post-split basis), and further adjusted to include 86,956 shares of Common Stock issued to the Reporting Person pursuant to the Securities Purchase Agreement dated February 13, 2026 (resulting in an estimated total of approximately 2,352,725 shares outstanding). The actual number of shares of Common Stock outstanding at the time of this filing may differ from the amount used in this calculation as a result of subsequent issuances, exercises of derivative securities, or other transactions by the Issuer.

**(b)**
The Chiliz Group (formally, HX Entertainment) has sole voting and dispositive power with respect to 305,644 shares of Common Stock.

**(c)**
The following transactions in the Common Stock were effected by the Chiliz Group (formally HX Entertainment) during the past sixty days.  Purchased on February 13, 2026 for $2.30 per share. Purchase of restricted securities pursuant to Securities Purchase Agreement dated February 13, 2026

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

On February 13, 2026, The Chiliz Group Ltd. entered into a Securities Purchase Agreement with the Issuer pursuant to which The Chiliz Group Ltd. purchased 86,956 shares of Common Stock at $2.30 per share for an aggregate subscription amount of $200,000. A copy of the Securities Purchase Agreement is filed as Exhibit A hereto.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** HX Entertainment Ltd

**Signature:** X

**Name/Title:** Alexandre Dreyfus

**Date:** 02/19/2026